People taking CGRP (calcitonin gene-related peptide) inhibitors had a 25% lower risk of developing glaucoma, compared to those taking other migraine meds, researchers report in the journal Neurology ...

Among 74,000 migraine patients, those taking CGRP inhibitors for migraine prevention had a 25% lower risk of incident ...

A type of drug used to prevent migraine may be associated with a reduced risk of glaucoma, according to a study published May ...

A type of drug used to prevent migraine may be associated with a reduced risk of glaucoma, according to a study published in ...

Nurtec ODT（rimegepant，口腔崩解片）已在美国获批上市，是第一个可同时用于偏头痛急性治疗和预防性治疗的cgrp受体拮抗剂。 NURTEC ODT (Rimegepant)是第一个也是唯一的具有快速溶解口腔崩解片剂型的降钙素基因相关肽(cgrp)受体拮抗剂，由美国食品药品监督管理局(FDA ...

Findings showed meloxicam/rizatriptan statistically significantly improved migraine treatment response compared with prior oral CGRP inhibitor treatment. Topline data were announced from a phase 3 ...

The first three calcitonin gene-related peptide (CGRP) inhibitors approved for prevention of migraine displayed a reassuring safety profile in real-world clinical practice during the first 6 months ...

Learn when to consider preventive migraine treatment, explore traditional and new therapies, and understand options like CGRP ...

Significantly reduced rate of acne and rosacea seen in patients treated with CGRPi mAbs vs triptans, topiramate. HealthDay News — For patients experiencing migraine, direct calcitonin gene-related ...

Calcitonin gene-related peptide (CGRP) inhibitors -- a group of drugs commonly used to treat migraine -- were associated with decreased rates of acne and rosacea compared with drugs that did not ...